drugset / Trial / NCT02710149
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to explore the therapeutic effect of CD20-targeted chimeric antigen receptor T(CAR-T) cells in the treatment of B cell malignancies.
Timeline
- Start
- 2016-03
- Primary completion
- 2020-03
- Completion
- 2021-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CD20-CAR-transduced T cells | Cell therapy | — | — |